RDEA-806, formerly known as AR-806 and VRX-806, is a reverse transcriptase inhibitor potentially for the treatment of HIV infection. References: La Regina G, Coluccia A, Silvestri R. Looking for an active conformation of the future HIV type-1 non-nucleoside reverse transcriptase inhibitors. Antivir Chem Chemother. 2010 Aug 11;20(6):213-37. doi: 10.3851/IMP1607. Review. PubMed PMID: 20710063.

纯度：≥98%

CAS：878670-61-2